European Commission claims pharma competition success

Legal Media Group


The proportion of problematic patent settlements in the pharmaceutical industry has fallen, even though the number of settlements has grown, according to the European Commission

In a statement published on January 31, the Commission said that its third annual survey had found that 11% of antitrust settlements were potentially problematic from an antitrust point of view, compared to 21% when the pharmaceutical sector enquiry was conducted in 2008 to 2009.

That came as the total number of settlements reached 120 in 2011,...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

In #mip50: @RMW136 @IPKenya @SpicyIP @patentlyo @jamie_love @copyrightgirl @Ipkat @ipwatchdog @DrRimmer @FOSSpatents http://t.co/902jHOwATj

Jul 22 2014 03:43 ·  reply ·  retweet ·  favourite
ManagingIP profile

Who are the most influential people in IP in 2014? #mip50 http://t.co/4SwWD8KKbt (Subscription/trial required for full access)

Jul 22 2014 03:36 ·  reply ·  retweet ·  favourite
ManagingIP profile

@metispartners Do they come with milk and sugar? #misscranston #IPassets

Jul 22 2014 02:46 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in Hong Kong



July/August 2014

IP’s most influential people 2014

The 50 people in social media, advocacy and debate influencing IP policy



Most read articles

Supplements